# Serological Assays for the Detection and Characterization of Influenza Viruses

Notice 7e726653fff340aca4149b3ddc889700 (solicitation 75D30125R73235) from HEALTH AND HUMAN SERVICES, DEPARTMENT OF, CDC OFFICE OF ACQUISITION SERVICES, posted 2025-03-18, responses due 2025-05-22T18:00:00.000Z. Status: open.

| Field | Value |
| --- | --- |
| Notice ID | 7e726653fff340aca4149b3ddc889700 |
| Solicitation number | 75D30125R73235 |
| Type | Solicitation |
| Agency | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Sub-tier | CENTERS FOR DISEASE CONTROL AND PREVENTION |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| Posted | 2025-03-18T18:27:39.000Z |
| Response deadline (UTC) | 2025-05-22T18:00:00.000Z |
| Set-aside | - |
| NAICS | 325413 |
| PSC | Q301 |
| Place of performance | Atlanta, GA, USA |
| Award | - |

## Description

Amendment 2 is being issued to amend the timeline for Phase I and Phase II, update terms per new Executive Orders, add Q&A, and require a verification from intersted labs of BSL-2 laboratory capability. The finalized version of the solicitation amendment is attached, along with the Q&A document, and the solicitation with the track changes. The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay. This is Phase I of a a two phased multi-step mandatory down select solicitation. Interest for Phase I is due to the contracting officer no later than 2:00 PM EST February 21, 2025. The steps in Phase I are as follows: Letter of Interest – offerors shall email POC information to Contracting Officer Proficiency panel will be sent by CDC to intersted offerors Vendor shall email results to CDC Contracting Officer CDC Contractng Officer will notify each offeror of their pass/fail status for Phase I and if they are then able to proceed to Phase II

## Sources

- View on SAM.gov: https://sam.gov/opp/7e726653fff340aca4149b3ddc889700/view
- Data as of 2026-11-14. Source: https://sam.gov/data-services/Contract%20Opportunities/datagov

## Cite this

"Serological Assays for the Detection and Characterization of Influenza Viruses, SAM.gov contract opportunity 7e726653fff340aca4149b3ddc889700." samgovapi.io, https://samgovapi.io/opportunity/7e726653fff340aca4149b3ddc889700, data as of 2026-11-14. Primary record: https://sam.gov/opp/7e726653fff340aca4149b3ddc889700/view

## API and MCP

- REST: GET https://samgovapi.io/api/v1/opportunities/7e726653fff340aca4149b3ddc889700
- MCP tool: get_opportunity

Independent. Not affiliated with, endorsed by or sponsored by GSA, SAM.gov or any U.S. government agency. Registering in SAM.gov is free at sam.gov.

Get a free API key: https://samgovapi.io/sign-up?ref=ai-claudebot